THE LONG–TERM OUTCOME OF S.M.A.R.T. VERSUS LUMINEXX NITINOL STENT IMPLAMTATION FOR AORTO–ILIAC ARTERY DISEASE

The primary endpoint was primary patency, while the secondary endpoints were primary assisted patency, secondary patency and major adverse limb events (MALE) that include all-cause death, myocardial infarction, stroke, major amputation and re-intervention.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2013-03, Vol.61 (10), p.E2082-E2082
Hauptverfasser: Shintani, Yoshiaki, Soga, Yoshimitsu, Iida, Osamu, Kawasaki, Daizo, Suzuki, Kenji, Hirano, Keisuke, Tazaki, Junichi, Miyashita, Yusuke, Kawasaki, Tomohiro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page E2082
container_issue 10
container_start_page E2082
container_title Journal of the American College of Cardiology
container_volume 61
creator Shintani, Yoshiaki
Soga, Yoshimitsu
Iida, Osamu
Kawasaki, Daizo
Suzuki, Kenji
Hirano, Keisuke
Tazaki, Junichi
Miyashita, Yusuke
Kawasaki, Tomohiro
description The primary endpoint was primary patency, while the secondary endpoints were primary assisted patency, secondary patency and major adverse limb events (MALE) that include all-cause death, myocardial infarction, stroke, major amputation and re-intervention.
doi_str_mv 10.1016/S0735-1097(13)62082-3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1673871999</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735109713620823</els_id><sourcerecordid>3657549461</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2323-dfb0ad8f018713b2784b50559908e7aa60bf4184fbb1caa522f134675dc5b4533</originalsourceid><addsrcrecordid>eNqF0MtKxDAUBuAgCo6XRxACbnTRmjRNLxuljBkNtI20GdFVaNMUquOMNiq48x18Q5_EzowouHGVzZ_vnPMDcICRixEOTkoUEupgFIdHmBwHHoo8h2yAEaY0cgiNw00w-olsgx1r7xBCQYTjEXiSlwymIr_4fP-QrMigmMqxyBgUE1i6mZu4hStdeM2KclrCdJrxnN3cwJxLnosUlpLlEvLsKk0ymUgucjgRBUxEIcUg8pQnY5gUg3wLz3nJkpLtga22mlmz__3ugumEyfGlk4oLPk5SR3vEI07T1qhqohbhKMSk9sLIrymiNI5RZMKqClDd-jjy27rGuqqo57WY-EFIG01rnxKyCw7X7mO_eHox9lndLV76-TBS4SAkgxrH8ZCi65TuF9b2plWPffdQ9W8KI7VsV63aVcvqFCZq1a5a6mfrf2Y44bUzvbK6M3Ntmq43-lk1i-5f4fSPoGfdvNPV7N68Gfu7rLKeQmtkaWCyEgj5Asaljdg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1673871999</pqid></control><display><type>article</type><title>THE LONG–TERM OUTCOME OF S.M.A.R.T. VERSUS LUMINEXX NITINOL STENT IMPLAMTATION FOR AORTO–ILIAC ARTERY DISEASE</title><source>Elsevier ScienceDirect Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Shintani, Yoshiaki ; Soga, Yoshimitsu ; Iida, Osamu ; Kawasaki, Daizo ; Suzuki, Kenji ; Hirano, Keisuke ; Tazaki, Junichi ; Miyashita, Yusuke ; Kawasaki, Tomohiro</creator><creatorcontrib>Shintani, Yoshiaki ; Soga, Yoshimitsu ; Iida, Osamu ; Kawasaki, Daizo ; Suzuki, Kenji ; Hirano, Keisuke ; Tazaki, Junichi ; Miyashita, Yusuke ; Kawasaki, Tomohiro</creatorcontrib><description>The primary endpoint was primary patency, while the secondary endpoints were primary assisted patency, secondary patency and major adverse limb events (MALE) that include all-cause death, myocardial infarction, stroke, major amputation and re-intervention.</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/S0735-1097(13)62082-3</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Cardiology ; Cardiovascular ; Heart attacks ; Internal Medicine ; Medical research</subject><ispartof>Journal of the American College of Cardiology, 2013-03, Vol.61 (10), p.E2082-E2082</ispartof><rights>American College of Cardiology Foundation</rights><rights>2013 American College of Cardiology Foundation</rights><rights>Copyright Elsevier Limited Mar 12, 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0735109713620823$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids></links><search><creatorcontrib>Shintani, Yoshiaki</creatorcontrib><creatorcontrib>Soga, Yoshimitsu</creatorcontrib><creatorcontrib>Iida, Osamu</creatorcontrib><creatorcontrib>Kawasaki, Daizo</creatorcontrib><creatorcontrib>Suzuki, Kenji</creatorcontrib><creatorcontrib>Hirano, Keisuke</creatorcontrib><creatorcontrib>Tazaki, Junichi</creatorcontrib><creatorcontrib>Miyashita, Yusuke</creatorcontrib><creatorcontrib>Kawasaki, Tomohiro</creatorcontrib><title>THE LONG–TERM OUTCOME OF S.M.A.R.T. VERSUS LUMINEXX NITINOL STENT IMPLAMTATION FOR AORTO–ILIAC ARTERY DISEASE</title><title>Journal of the American College of Cardiology</title><description>The primary endpoint was primary patency, while the secondary endpoints were primary assisted patency, secondary patency and major adverse limb events (MALE) that include all-cause death, myocardial infarction, stroke, major amputation and re-intervention.</description><subject>Cardiology</subject><subject>Cardiovascular</subject><subject>Heart attacks</subject><subject>Internal Medicine</subject><subject>Medical research</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqF0MtKxDAUBuAgCo6XRxACbnTRmjRNLxuljBkNtI20GdFVaNMUquOMNiq48x18Q5_EzowouHGVzZ_vnPMDcICRixEOTkoUEupgFIdHmBwHHoo8h2yAEaY0cgiNw00w-olsgx1r7xBCQYTjEXiSlwymIr_4fP-QrMigmMqxyBgUE1i6mZu4hStdeM2KclrCdJrxnN3cwJxLnosUlpLlEvLsKk0ymUgucjgRBUxEIcUg8pQnY5gUg3wLz3nJkpLtga22mlmz__3ugumEyfGlk4oLPk5SR3vEI07T1qhqohbhKMSk9sLIrymiNI5RZMKqClDd-jjy27rGuqqo57WY-EFIG01rnxKyCw7X7mO_eHox9lndLV76-TBS4SAkgxrH8ZCi65TuF9b2plWPffdQ9W8KI7VsV63aVcvqFCZq1a5a6mfrf2Y44bUzvbK6M3Ntmq43-lk1i-5f4fSPoGfdvNPV7N68Gfu7rLKeQmtkaWCyEgj5Asaljdg</recordid><startdate>20130312</startdate><enddate>20130312</enddate><creator>Shintani, Yoshiaki</creator><creator>Soga, Yoshimitsu</creator><creator>Iida, Osamu</creator><creator>Kawasaki, Daizo</creator><creator>Suzuki, Kenji</creator><creator>Hirano, Keisuke</creator><creator>Tazaki, Junichi</creator><creator>Miyashita, Yusuke</creator><creator>Kawasaki, Tomohiro</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20130312</creationdate><title>THE LONG–TERM OUTCOME OF S.M.A.R.T. VERSUS LUMINEXX NITINOL STENT IMPLAMTATION FOR AORTO–ILIAC ARTERY DISEASE</title><author>Shintani, Yoshiaki ; Soga, Yoshimitsu ; Iida, Osamu ; Kawasaki, Daizo ; Suzuki, Kenji ; Hirano, Keisuke ; Tazaki, Junichi ; Miyashita, Yusuke ; Kawasaki, Tomohiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2323-dfb0ad8f018713b2784b50559908e7aa60bf4184fbb1caa522f134675dc5b4533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Cardiology</topic><topic>Cardiovascular</topic><topic>Heart attacks</topic><topic>Internal Medicine</topic><topic>Medical research</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shintani, Yoshiaki</creatorcontrib><creatorcontrib>Soga, Yoshimitsu</creatorcontrib><creatorcontrib>Iida, Osamu</creatorcontrib><creatorcontrib>Kawasaki, Daizo</creatorcontrib><creatorcontrib>Suzuki, Kenji</creatorcontrib><creatorcontrib>Hirano, Keisuke</creatorcontrib><creatorcontrib>Tazaki, Junichi</creatorcontrib><creatorcontrib>Miyashita, Yusuke</creatorcontrib><creatorcontrib>Kawasaki, Tomohiro</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shintani, Yoshiaki</au><au>Soga, Yoshimitsu</au><au>Iida, Osamu</au><au>Kawasaki, Daizo</au><au>Suzuki, Kenji</au><au>Hirano, Keisuke</au><au>Tazaki, Junichi</au><au>Miyashita, Yusuke</au><au>Kawasaki, Tomohiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>THE LONG–TERM OUTCOME OF S.M.A.R.T. VERSUS LUMINEXX NITINOL STENT IMPLAMTATION FOR AORTO–ILIAC ARTERY DISEASE</atitle><jtitle>Journal of the American College of Cardiology</jtitle><date>2013-03-12</date><risdate>2013</risdate><volume>61</volume><issue>10</issue><spage>E2082</spage><epage>E2082</epage><pages>E2082-E2082</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>The primary endpoint was primary patency, while the secondary endpoints were primary assisted patency, secondary patency and major adverse limb events (MALE) that include all-cause death, myocardial infarction, stroke, major amputation and re-intervention.</abstract><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/S0735-1097(13)62082-3</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0735-1097
ispartof Journal of the American College of Cardiology, 2013-03, Vol.61 (10), p.E2082-E2082
issn 0735-1097
1558-3597
language eng
recordid cdi_proquest_journals_1673871999
source Elsevier ScienceDirect Journals; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Cardiology
Cardiovascular
Heart attacks
Internal Medicine
Medical research
title THE LONG–TERM OUTCOME OF S.M.A.R.T. VERSUS LUMINEXX NITINOL STENT IMPLAMTATION FOR AORTO–ILIAC ARTERY DISEASE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T12%3A08%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=THE%20LONG%E2%80%93TERM%20OUTCOME%20OF%20S.M.A.R.T.%20VERSUS%20LUMINEXX%20NITINOL%20STENT%20IMPLAMTATION%20FOR%20AORTO%E2%80%93ILIAC%20ARTERY%20DISEASE&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Shintani,%20Yoshiaki&rft.date=2013-03-12&rft.volume=61&rft.issue=10&rft.spage=E2082&rft.epage=E2082&rft.pages=E2082-E2082&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/S0735-1097(13)62082-3&rft_dat=%3Cproquest_cross%3E3657549461%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1673871999&rft_id=info:pmid/&rft_els_id=S0735109713620823&rfr_iscdi=true